Variant report

Variant	rs3755953
Chromosome Location	chr4:1162694-1162695
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:1161114..1165211-chr4:1166165..1170804,4	MCF-7	breast:
2	chr4:1158166..1163360-chr4:1238498..1245354,13	MCF-7	breast:
3	chr4:1160924..1165328-chr4:1340425..1343058,5	MCF-7	breast:
4	chr4:1161675..1163555-chr4:1169840..1172430,2	MCF-7	breast:
5	chr4:1005928..1008320-chr4:1161466..1163793,2	MCF-7	breast:
6	chr4:1161599..1163141-chr4:1169473..1171016,2	K562	blood:
7	chr4:1157316..1159655-chr4:1161793..1164366,2	K562	blood:
8	chr4:1160471..1164177-chr4:1164804..1166602,3	K562	blood:
9	chr4:1159747..1163015-chr4:1240558..1244483,3	K562	blood:
10	chr4:1159320..1162756-chr4:1282339..1286135,5	K562	blood:

No data

Variant related genes	Relation type
ENSG00000196810	Chromatin interaction
ENSG00000159674	Chromatin interaction
ENSG00000090316	Chromatin interaction
ENSG00000163945	Chromatin interaction
ENSG00000127418	Chromatin interaction
ENSG00000159692	Chromatin interaction

Extended variants
information (count: 32 )
Associated
traits (count: 2 )

rSNPs within LD-proxies of this variant (count:12)

rs_ID	r²[population]
rs10014526	0.92[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.80[YRI][hapmap];0.81[AFR][1000 genomes];0.92[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs10020143	0.87[AMR][1000 genomes];0.92[ASN][1000 genomes]
rs11538062	0.85[AFR][1000 genomes];0.82[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs11937228	0.92[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs28478922	0.86[ASN][1000 genomes]
rs28660089	0.80[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs28750743	0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs28883944	0.87[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs28886387	0.87[AFR][1000 genomes];0.95[AMR][1000 genomes];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs60044123	0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs62293577	0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs73792281	0.85[AMR][1000 genomes];0.93[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:20 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv822425	chr4:540105-1413799	Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers ZNF genes & repeats Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	108 gene(s)	inside rSNPs	diseases
2	nsv530490	chr4:614355-1399150	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
3	nsv536980	chr4:827866-1167377	Active TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
4	nsv1009619	chr4:901897-1215657	Strong transcription Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
5	nsv1003876	chr4:927509-1191316	Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Strong transcription Active TSS Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
6	nsv1000381	chr4:927509-1198766	Weak transcription Enhancers Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
7	esv3339080	chr4:970630-1546223	Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	82 gene(s)	inside rSNPs	diseases
8	nsv1005990	chr4:1015652-1167619	Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
9	nsv1012892	chr4:1086871-1176630	Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
10	nsv829835	chr4:1097586-1304239	Enhancers Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	59 gene(s)	inside rSNPs	diseases
11	nsv878328	chr4:1141573-1990425	Weak transcription Flanking Active TSS Enhancers Strong transcription Genic enhancers Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	121 gene(s)	inside rSNPs	diseases
12	nsv878329	chr4:1147407-1254930	Genic enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Weak transcription Active TSS Strong transcription Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	49 gene(s)	inside rSNPs	diseases
13	nsv878330	chr4:1147407-1523930	Strong transcription Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
14	nsv519106	chr4:1158991-1174861	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
15	nsv593276	chr4:1159680-1227469	Flanking Active TSS Genic enhancers Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
16	nsv461151	chr4:1159680-1236840	Enhancers Flanking Bivalent TSS/Enh Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
17	nsv593277	chr4:1159680-1236840	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
18	nsv878331	chr4:1159680-1254930	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Strong transcription Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	49 gene(s)	inside rSNPs	diseases
19	nsv461152	chr4:1159680-1415698	Enhancers Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	70 gene(s)	inside rSNPs	diseases
20	nsv593278	chr4:1159680-1415698	Enhancers Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	70 gene(s)	inside rSNPs	diseases

mRNA abundance (count:2)

SNP	Gene	Cis/trans	Tissue	Source
rs3755953	CRIPAK	Cis_1M	lymphoblastoid	RTeQTL
rs3755953	KIAA1530	Cis_1M	lymphoblastoid	RTeQTL

Chromatin state (count:47 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:1160400-1163400	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr4:1161800-1162800	Weak transcription	Lung	lung
3	chr4:1161800-1163000	Weak transcription	Ovary	ovary
4	chr4:1161800-1163000	Weak transcription	Pancreas	Pancrea
5	chr4:1161800-1163200	Weak transcription	Gastric	stomach
6	chr4:1161800-1163400	Weak transcription	HepG2	liver
7	chr4:1161800-1163800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr4:1161800-1163800	Weak transcription	Muscle Satellite Cultured Cells	--
9	chr4:1161800-1163800	Enhancers	Adipose Nuclei	Adipose
10	chr4:1161800-1164000	Bivalent Enhancer	Placenta	Placenta
11	chr4:1161800-1164000	Enhancers	Skeletal Muscle Female	skeletal muscle
12	chr4:1161800-1164000	Genic enhancers	NHLF	lung
13	chr4:1161800-1164200	Bivalent Enhancer	Fetal Stomach	stomach
14	chr4:1161800-1164600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr4:1161800-1165000	Weak transcription	Right Atrium	heart
16	chr4:1161800-1165200	Transcr. at gene 5' and 3'	Primary Natural Killer cells fromperipheralblood	blood
17	chr4:1162000-1162800	Enhancers	Primary T helper naive cells from peripheral blood	blood
18	chr4:1162000-1162800	Bivalent Enhancer	Brain Germinal Matrix	brain
19	chr4:1162000-1163200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
20	chr4:1162000-1163400	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
21	chr4:1162000-1164200	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin01	Skin
22	chr4:1162000-1164600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
23	chr4:1162000-1165200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
24	chr4:1162000-1165200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
25	chr4:1162000-1165200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
26	chr4:1162000-1166200	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr4:1162200-1163000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
28	chr4:1162200-1163000	Weak transcription	Right Ventricle	heart
29	chr4:1162200-1163800	Weak transcription	Colon Smooth Muscle	Colon
30	chr4:1162200-1164400	Strong transcription	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr4:1162400-1162800	Bivalent Enhancer	Colonic Mucosa	Colon
32	chr4:1162400-1162800	Enhancers	GM12878-XiMat	blood
33	chr4:1162400-1163000	Enhancers	Dnd41	blood
34	chr4:1162400-1163200	Weak transcription	Duodenum Smooth Muscle	Duodenum
35	chr4:1162400-1163600	Genic enhancers	Fetal Muscle Leg	muscle
36	chr4:1162400-1164000	Genic enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr4:1162400-1164800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
38	chr4:1162600-1162800	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
39	chr4:1162600-1162800	Enhancers	HSMM	muscle
40	chr4:1162600-1163000	Bivalent Enhancer	Rectal Smooth Muscle	rectum
41	chr4:1162600-1163000	Weak transcription	Spleen	Spleen
42	chr4:1162600-1163600	Strong transcription	Liver	Liver
43	chr4:1162600-1164000	Strong transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr4:1162600-1164200	Enhancers	Stomach Smooth Muscle	stomach
45	chr4:1162600-1164400	Genic enhancers	NHDF-Ad	bronchial
46	chr4:1162600-1164800	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
47	chr4:1162600-1165200	Genic enhancers	Esophagus	oesophagus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links